Funding for pandemic influenza antivirals in the LHHS Appropriations bill. Regulatory and legislative issues related to development and procurement of pandemic influenza antivirals. Issues related to domestic manufacturing and on-shoring pharmaceuticals.
Lobbyists: mrs KELLY CHILDRESS LANGE (covered position: Rep. Shimkus, LA; Rep. Rogers, Health Policy Adviser.)
Government entities lobbied:Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office
TAR — Tariff (miscellaneous tariff bills)
Section 232 investigation into pharmaceuticals and unfair trade practices.
Lobbyists: mrs KELLY CHILDRESS LANGE (covered position: Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor)
Government entities lobbied:Commerce, Dept of (DOC); U.S. Trade Representative (USTR); White House Office
MAN — Manufacturing
Buy America legislation, 232 tariff investigation, regulatory incentives for domestic manufacturing.
Lobbyists: mrs KELLY CHILDRESS LANGE (covered position: Rep. Shimkus, LA; Rep. Rogers, Health Policy Advisor)
Government entities lobbied:Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; White House Office
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page. Want to partner? Contact us.
Estimated value: $540/mo per user — but we made it free.